Find out all about your favorite commercial!

Advertisers

Advertisers of the Keytruda TV Spot, 'It's TRU: Katy and Dr. Kloecker's Story: Living Longer Is Possible'

Keytruda TV commercial - Its TRU: Katy and Dr. Kloeckers Story: Living Longer Is Possible
Keytruda

Keytruda is a brand name for pembrolizumab, an immunotherapy drug developed and marketed by Merck & Co. It was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of adva...

What the Keytruda TV commercial - Its TRU: Katy and Dr. Kloeckers Story: Living Longer Is Possible is about.

Keytruda TV commercial - Its TRU: Katy and Dr. Kloeckers Story: Living Longer Is Possible

Title: Keytruda TV Spot: Living Longer Is Possible

Introduction:In the heartwarming television spot for Keytruda, titled "It's TRU: Katy and Dr. Kloecker's Story: Living Longer Is Possible," we are introduced to Katy, a brave cancer survivor, and Dr. Kloecker, her compassionate oncologist. This emotionally charged commercial takes viewers on a journey of hope and showcases how Keytruda, a groundbreaking immunotherapy, has transformed Katy's life by offering her a chance at a longer and healthier future.

A Glimpse into Katy's Story:The TV spot opens with a glimpse of Katy, a vibrant woman who exudes strength and determination. We see her engaging in various everyday activities, surrounded by her supportive family. The warm visuals and uplifting background music tug at our heartstrings, instantly capturing our attention.

Narration and Dialogue:The narrator's soothing voice takes us through Katy's cancer diagnosis and her subsequent treatment with Keytruda. However, it is the poignant exchange between Katy and Dr. Kloecker that truly grabs our attention. The TV spot strategically includes a deep and heartfelt conversation that breaks down the complex science behind Keytruda in an accessible way, ensuring viewers can understand the potential of this innovative treatment.

Katy's Journey with Keytruda:As the commercial progresses, we witness Katy's transformative journey with Keytruda. Through a series of carefully crafted scenes, we witness her gradually regaining her physical strength and vivacity. Katy's radiance shines through as she participates in activities she thought she would never be able to enjoy again – hiking with her family, attending social events, and relishing moments of pure joy.

Alongside Katy's narrative, the TV spot also provides brief but crucial insights into the science behind Keytruda. Visual representations of the immune system's response to cancer and the role Keytruda plays in combating the disease add context and enhance viewers' understanding of the treatment's efficacy.

The Emotional Impact:The commercial's emotional impact crescendos as we witness the gratitude in Katy's eyes and the unspoken bond between her and Dr. Kloecker. Real-life testimonials from other patients who've experienced similar outcomes further amplify the commercial's message and inspire hope in those facing similar battles.

Conclusion:The Keytruda TV spot, "It's TRU: Katy and Dr. Kloecker's Story: Living Longer Is Possible," effectively combines powerful storytelling, heartwarming visuals, and informative dialogue to convey the life-changing potential of Keytruda in the treatment of cancer. By centering the narrative around a real patient's experience and the physician who guided her through her journey, this advertisement not only educates viewers but also instills a sense of hope and optimism for those facing similar challenges. It reminds us that with innovative treatments like Keytruda, living longer and thriving in the face of adversity is indeed possible.

Keytruda TV commercial - Its TRU: Katy and Dr. Kloeckers Story: Living Longer Is Possible produced for Keytruda was first shown on television on January 6, 2019.

Frequently Asked Questions about keytruda tv spot, 'it's tru: katy and dr. kloecker's story: living longer is possible'

Merck has now added a real doctor to its TV ad for Keytruda (pembrolizumab), the cancer immunotherapeutic. Two new ads – one featuring Dr. Goetz Kloecker, a practicing oncologist, alone and one featuring Dr.

Half (50%) of the patients who received Keytruda every 3 weeks were alive at 4.1 months, compared to 2.8 months for patients receiving Yervoy. Keytruda was shown to reduce the risk of dying by 31% compared to Yervoy.

KEYTRUDA blocks the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what it was meant to do: detect and fight cancer cells.

Patients receiving Keytruda lived for 10.3 months (median overall survival) compared to 7.4 months with chemotherapy.

Some patients can stay on KEYTRUDA for up to a year or two. Your doctor will decide how long you will be on treatment.

KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death. You can have more than one of these problems at the same time.

The average overall survival duration among Keytruda treated patients is now 26.3 months compared to 14.2 months for those treated with chemotherapy. The 36-month overall survival is 43.7% for Keytruda compared to 24.9% for chemotherapy.

Patient-reported quality of life was better for patients with resected melanoma who received Keytruda compared to interferon or Yervoy, study results showed.

Patients receiving Keytruda lived for 10.3 months (median overall survival) compared to 7.4 months with chemotherapy.

Research published this February noted that many patients are living longer after receiving immunotherapy, which activates the body's own immune system to recognize and kill cancer cells.

Immunotherapy Benefit for Advanced Lung Cancer Continues Beyond 2 Years. Limiting immunotherapy to 2 years doesn't decrease survival odds, but may reduce bothersome side effects and improve quality of life.

Patients receiving Keytruda lived for 10.3 months (median overall survival) compared to 7.4 months with chemotherapy.

Videos

Watch Keytruda TV Commercial, 'It's TRU: Katy and Dr. Kloecker's Story: Living Longer Is Possible'

Unfortunately we were unable to find any suitable videos in the public domain. Perhaps the video of this TV commercial has not been preserved. If you know the link to this commercial, you can send it to us using a special form.

Agenices

Agenices of the Keytruda TV Spot, 'It's TRU: Katy and Dr. Kloecker's Story: Living Longer Is Possible'

Keytruda TV commercial - Its TRU: Katy and Dr. Kloeckers Story: Living Longer Is Possible
Initiative

A company initiative is a pro-active effort undertaken by a business to achieve a specific objective or goal. These initiatives can vary widely in scope and focus, including everything from internal p...

Products

Products Advertised

Keytruda
TV commercials

Similar commercials

Keytruda TV Spot, 'It's TRU: Dr. Kloecker's Story: Living Longer Is Possible'
Volkswagen Atlas TV Spot, 'Bumble' [T1]
Lexus Golden Opportunity Sales Event TV Spot, 'Venture Further'
Wizard 101 TV Spot, 'Challenge'
956 February 22, 2013
Keytruda TV Spot, 'It's TRU: Donna's Story - Living Longer Is Possible'
Opdivo TV Spot, 'A Chance to Live Longer'
Neulasta TV Spot, 'Sisters'
991 July 20, 2015
Volkswagen Atlas TV Spot, 'Sleeps Six' [T1]
Dave and Buster's TV Spot, 'FX Pours: Coolest Cocktail Creations'
Neulasta Onpro TV Spot, 'Stay at Home: $5'
National Car Rental TV Spot, 'Professionals'
2016 Lexus LS & LX TV Spot, 'Different Route'